Tate Susan M 4

4 · HCP, INC. · Filed Feb 21, 2013

Form 4

Period: 2013-02-21

Executive Vice President

Transactions

Exercise/Conversion
Employee Stock Option
2013-02-21−10,056→ 10,056 total
Exercise: $23.34From: 2009-01-30Exp: 2019-01-30→ Common Stock (10,056 underlying)
Exercise/Conversion
Common Stock
2013-02-21$31.95/sh+4,958$158,408→ 52,037 total
Exercise/Conversion
Common Stock
2013-02-21$28.35/sh+4,642$131,601→ 66,735 total
Exercise/Conversion
Employee Stock Option
2013-02-21−4,958→ 6,612 total
Exercise: $31.95From: 2008-01-25Exp: 2018-01-25→ Common Stock (4,958 underlying)
Exercise/Conversion
Employee Stock Option
2013-02-21−4,642→ 9,284 total
Exercise: $28.35From: 2010-01-29Exp: 2020-01-29→ Common Stock (4,642 underlying)
Exercise/Conversion
Common Stock
2013-02-21$23.34/sh+10,056$234,707→ 62,093 total
Sale
Common Stock
2013-02-21$48.06/sh−19,656$944,689→ 47,079 total

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at sale prices ranging from $48.0600 to $48.0710. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
[F2]Stock options vest 20% annually commencing on the first anniversary of the January 25, 2008 grant date and are fully exercisable.
[F3]Stock options vest 20% annually commencing on the first anniversary of the January 30, 2009 grant date.
[F4]Stock options vest 20% annually commencing on the first anniversary of the January 29, 2010 grant date.

Documents

1 file